Effect of hypoxia-inducible factor-1 on transcription of survivin in non-small cell lung cancer

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Chen, Yu Qing ^a   Zhao, Cheng Ling ^a   Li, Wei ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; SURVIVIN; BIRC5 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ADULT; AGED; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; WESTERN BLOTTING; APOPTOSIS; BIOSYNTHESIS; CELL GROWTH; CELL HYPOXIA; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ADULT; AGED; APOPTOSIS; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; CELL HYPOXIA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 63849178889     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-29     Document Type: Article

References (29)

1. Control of apoptosis and mitotic spindle checkpoint by survivin. F Li G Ambrosini EY Chu J Plescia S Tognin PC Marchisio DC Altieri, Nature 1998 396 6711 580 584 10.1038/25141 9859993
2. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. F Li EJ Ackermann CF Bennett AL Rothermel J Plescia S Tognin A Villa PC Marchisio DC Altieri, Nat Cell Biol 1999 1 8 461 466 10.1038/70242 10587640
3. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. G Ambrosini C Adida DC Altieri, Nat Med 1997 3 8 917 921 10.1038/nm0897-917 9256286
4. IAP family proteins-suppressors of apoptosis. QL Deveraux JC Reed, Genes Dev 1999 13 3 239 252 10.1101/gad.13.3.239 9990849
5. Survivin study: what is the next wave? F Li, J Cell Physiol 2003 197 1 8 29 10.1002/jcp.10327 12942537
6. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. F Rodel J Hoffmann L Distel M Herrmann T Noisternig T Papadopoulos R Sauer C Rodel, Cancer Res 2005 65 11 4881 4887 10.1158/0008-5472.CAN-04-3028 15930309
7. Silencing of antiapoptotic survivin gene by multiple approaches of RNA interference technology. X Ling F Li, Biotechniques 2004 36 3 450 454 15038160
8. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. SP Tu XH Jiang MC Lin JT Cui Y Yang CT Lum B Zou YB Zhu SH Jiang WM Wong, Cancer Res 2003 63 22 7724 7732 14633697
9. Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. M Pennati G Colella M Folini L Citti MG Daidone N Zaffaroni, J Clin Invest 2002 109 2 285 286 11805141
10. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. M Pennati M Binda G Colella M Zoppe M Folini S Vignati A Valentini L Citti M De Cesare G Pratesi, Oncogene 2004 23 2 386 394 10.1038/sj.onc.1207071 14724567
11. Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. C Shen A Buck B Polat A Schmid-Kotsas C Matuschek HJ Gross M Bachem SN Reske, Cancer Gene Ther 2003 10 5 403 410 10.1038/sj.cgt.7700581 12719710
12. Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment. M Zhang J Yang F Li, J Exp Clin Cancer Res 2006 25 3 391 402 17167980
13. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. JY Chun Y Hu E Pinder J Wu F Li AC Gao, Mol Cancer Ther 2007 6 9 2572 2580 10.1158/1535-7163.MCT-07-0172 17876054
14. Transcriptional analysis of human survivin gene expression. F Li DC Altieri, Biochem J 1999 344 Pt 2 305 311 10567210 10.1042/0264-6021:3440305
15. KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia. N Zhu L Gu HW Findley C Chen JT Dong L Yang M Zhou, J Biol Chem 2006 281 21 14711 14718 10.1074/jbc.M513810200 16595680
16. Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? L Harrison K Blackwell, Oncologist 2004 9 Suppl 5 31 40 10.1634/theoncologist.9-90005-31 15591420
17. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. M Hockel K Schlenger B Aral M Mitze U Schaffer P Vaupel, Cancer Res 1996 56 19 4509 4515 8813149
18. Cancer: Out of air is not out of action. DP Bottaro LA Liotta, Nature 2003 423 6940 593 595 10.1038/423593a 12789320
19. Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer. Q Chang R Qin T Huang J Gao Y Feng, Pancreas 2006 32 3 297 305 10.1097/00006676-200604000-00010 16628086
20. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. XH Peng P Karna Z Cao BH Jiang M Zhou L Yang, J Biol Chem 2006 281 36 25903 25914 10.1074/jbc.M603414200 16847054
21. Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia. HM Sowter RR Raval JW Moore PJ Ratcliffe AL Harris, Cancer Res 2003 63 19 6130 6134 14559790
22. Apoptotic pathways as targets for therapeutic intervention. D Vucic, Curr Cancer Drug Targets 2008 8 2 86 10.2174/156800908783769364 18336190
23. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. WL Blalock C Weinstein-Oppenheimer F Chang PE Hoyle XY Wang PA Algate RA Franklin SM Oberhaus LS Steelman JA McCubrey, Leukemia 1999 13 8 1109 1166 10.1038/sj/leu/2401493 10450743
24. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells. PO Esteve HG Chin S Pradhan, J Biol Chem 2007 282 4 2615 2625 10.1074/jbc.M606203200 17124180
25. Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug. K Kawamura L Yu M Tomizawa O Shimozato G Ma Q Li A Sato Y Yang T Suzuki NM Abdel-Aziz, Anticancer Res 2007 27 1A 89 93 17352220
26. Suppression of colorectal tumor growth by regulated survivin targeting. B Li J Fan X Liu R Qi L Bo J Gu C Qian X Liu, J Mol Med 2006 84 12 1077 1086 10.1007/s00109-006-0106-9 17077982
27. Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity. J Wu X Ling D Pan P Apontes L Song P Liang DC Altieri T Beerman F Li, J Biol Chem 2005 280 10 9745 9751 10.1074/jbc.M409350200 15637054
28. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. R Bos P van der Groep AE Greijer A Shvarts S Meijer HM Pinedo GL Semenza PJ van Diest E van der Wall, Cancer 2003 97 6 1573 1581 10.1002/cncr.11246 12627523
29. Hypoxia and drug resistance. BA Teicher, Cancer Metastasis Rev 1994 13 2 139 168 10.1007/BF00689633 7923547